DOCS (Doximity) Piotroski F-Score: 5 (As of Jun. 24, 2026) — 17% Below Median


DOCS Doximity Inc DOCS
82 GF Score
Price $20.83
GF Value $49.17
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Doximity Piotroski F-Score?

Doximity DOCS +1.71% 82 Piotroski F-Score is 5 as of Jun. 24, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.17 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Doximity ranks better than 54.38% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Doximity has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Doximity's Piotroski F-Score or its related term are showing as below:

DOCS' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 8
Current: 5

During the past 8 years, the highest Piotroski F-Score of Doximity was 8. The lowest was 4. And the median was 6.

Doximity  (NYSE:DOCS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Doximity Piotroski F-Score Related Terms


Doximity Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Doximity's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doximity Piotroski F-Score Chart

Doximity Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial 6.00 4.00 7.00 8.00 5.00

Doximity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 7.00 8.00 6.00 5.00

DOCS vs WAY, TXG, HNGE: Piotroski F-Score Comparison

For the Health Information Services subindustry, Doximity's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doximity Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Doximity's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Doximity's Piotroski F-Score falls into.


DOCS
82GF Score
Doximity Inc DOCS
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 53.32 + 62.059 + 61.558 + 19.114 = $196.1 Mil.
Cash Flow from Operations was 62.101 + 93.944 + 60.891 + 109.522 = $326.5 Mil.
Revenue was 145.913 + 168.525 + 185.053 + 145.372 = $644.9 Mil.
Gross Profit was 130.12 + 152.1 + 166.352 + 125.965 = $574.5 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(1264.309 + 1204.447 + 1257.109 + 1157.026 + 1123.687) / 5 = $1201.3156 Mil.
Total Assets at the begining of this year (Mar25) was $1,264.3 Mil.
Long-Term Debt & Capital Lease Obligation was $8.1 Mil.
Total Current Assets was $944.3 Mil.
Total Current Liabilities was $155.0 Mil.
Net Income was 41.377 + 44.154 + 75.196 + 62.458 = $223.2 Mil.

Revenue was 126.676 + 136.832 + 168.603 + 138.288 = $570.4 Mil.
Gross Profit was 113.126 + 123.156 + 154.422 + 123.821 = $514.5 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(1079.374 + 1073.458 + 1118.516 + 1172.157 + 1264.309) / 5 = $1141.5628 Mil.
Total Assets at the begining of last year (Mar24) was $1,079.4 Mil.
Long-Term Debt & Capital Lease Obligation was $10.2 Mil.
Total Current Assets was $1,088.6 Mil.
Total Current Liabilities was $156.3 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Doximity's current Net Income (TTM) was 196.1. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Doximity's current Cash Flow from Operations (TTM) was 326.5. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=196.051/1264.309
=0.15506573

ROA (Last Year)=Net Income/Total Assets (Mar24)
=223.185/1079.374
=0.20677263

Doximity's return on assets of this year was 0.15506573. Doximity's return on assets of last year was 0.20677263. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Doximity's current Net Income (TTM) was 196.1. Doximity's current Cash Flow from Operations (TTM) was 326.5. ==> 326.5 > 196.1 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=8.075/1201.3156
=0.0067218

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=10.185/1141.5628
=0.00892198

Doximity's gearing of this year was 0.0067218. Doximity's gearing of last year was 0.00892198. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=944.264/154.973
=6.09308718

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1088.62/156.257
=6.96685588

Doximity's current ratio of this year was 6.09308718. Doximity's current ratio of last year was 6.96685588. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Doximity's number of shares in issue this year was 195.067. Doximity's number of shares in issue last year was 202.957. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=574.537/644.863
=0.89094428

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=514.525/570.399
=0.90204401

Doximity's gross margin of this year was 0.89094428. Doximity's gross margin of last year was 0.90204401. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=644.863/1264.309
=0.51005174

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=570.399/1079.374
=0.52845353

Doximity's asset turnover of this year was 0.51005174. Doximity's asset turnover of last year was 0.52845353. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Doximity has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Doximity (DOCS) has a Piotroski F-Score of 5 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Doximity and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Doximity's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, Doximity ranks #297 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 45.6%.
Is Doximity's Piotroski F-Score too high?
Doximity's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Doximity's value of 5 is 0% at this industry median. Based on the distribution chart, Doximity ranks #297 out of 651 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's Piotroski F-Score compare to WAY and TXG?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #297 out of 651 companies for Piotroski F-Score. This puts Doximity in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Doximity's value of 5 is 0% at this benchmark. Historically, Doximity's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Doximity has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Doximity and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.17, compared to a current price of $20.83 — trading 57.6% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Doximity (DOCS), the current Piotroski F-Score is 5 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doximity (DOCS) Overvalued in 2026?

Based on GuruFocus' analysis, Doximity stock appears to be undervalued. The current stock price of $20.83 is trading 57.6% below its estimated GF Value™ of $49.17. GuruFocus considers Doximity to be Significantly Undervalued.

Key valuation signals for DOCS:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: $49.17 vs. price of $20.83 (57.6% below fair value)
  • GF Score™: 82/100 with 2 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#297 of 651)

No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Doximity Business Description

Other Exchanges D2OC34:Brazil
Address 500 3rd Street, Suite 510, San Francisco, CA, USA, 94107
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score

Get the complete analysis for DOCS

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.83
Price
$49.17
GF Value